3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
22 22 0 0 0 0 0 0 0999 V2000
-4.6156 -0.3497 -0.5311 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.1159 -0.0164 0.7058 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1883 -0.9440 -0.8963 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6522 0.9025 0.3248 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9140 1.0610 0.0249 C 1 0 0 0 0 0 0 0 0 0 0 0
-0.2138 -0.0803 0.4161 C 1 0 0 0 0 0 0 0 0 0 0 0
-2.2751 0.9779 -0.2682 C 1 0 0 0 0 0 0 0 0 0 0 0
-0.8749 -1.3047 0.5142 C 1 0 0 0 0 0 0 0 0 0 0 0
-0.2220 2.3794 -0.0861 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9363 -0.2465 -0.1700 C 1 0 0 0 0 0 0 0 0 0 0 0
-2.2361 -1.3878 0.2214 C 1 0 0 0 0 0 0 0 0 0 0 0
1.9900 -0.8222 -0.0824 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3411 -0.1691 -0.1732 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8230 1.8664 -0.5737 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.3448 -2.2006 0.8257 H 0 0 0 0 0 0 0 0 0 0 0 0
0.2088 2.6653 0.8792 H 0 0 0 0 0 0 0 0 0 0 0 0
0.5764 2.3272 -0.8338 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.9072 3.1779 -0.3901 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.7387 -2.3481 0.3041 H 0 0 0 0 0 0 0 0 0 0 0 0
2.1025 -1.7975 0.4021 H 0 0 0 0 0 0 0 0 0 0 0 0
1.6001 -0.9388 -1.1008 H 0 0 0 0 0 0 0 0 0 0 0 0
5.0794 -0.5407 -0.9713 H 0 0 0 0 0 0 0 0 0 0 0 0
1 10 1 0 0 0 0
2 6 1 0 0 0 0
2 12 1 0 0 0 0
3 13 1 0 0 0 0
3 22 1 0 0 0 0
4 13 2 0 0 0 0
5 6 2 0 0 0 0
5 7 1 0 0 0 0
5 9 1 0 0 0 0
6 8 1 0 0 0 0
7 10 2 0 0 0 0
7 14 1 0 0 0 0
8 11 2 0 0 0 0
8 15 1 0 0 0 0
9 16 1 0 0 0 0
9 17 1 0 0 0 0
9 18 1 0 0 0 0
10 11 1 0 0 0 0
11 19 1 0 0 0 0
12 13 1 0 0 0 0
12 20 1 0 0 0 0
12 21 1 0 0 0 0
M ISO 6 5 13 6 13 7 13 8 13 10 13 11 13
4. 国际命名与标识
4.1 IUPAC Name
2-(4-chloro-2-methyl(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)oxyacetic acid
4.2 InChl
InChI=1S/C9H9ClO3/c1-6-4-7(10)2-3-8(6)13-5-9(11)12/h2-4H,5H2,1H3,(H,11,12)/i2+1,3+1,4+1,6+1,7+1,8+1
4.3 InChlKey
WHKUVVPPKQRRBV-BOCFXHSMSA-N
4.4 Canonical SMILES
CC1=C(C=CC(=C1)Cl)OCC(=O)O
4.5 lsomeric SMILES
C[13C]1=[13C]([13CH]=[13CH][13C](=[13CH]1)Cl)OCC(=O)O
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病